The invasive practice of suturing for wound closure has persisted for millennia; with the rate of medical development, it is staggering that there are few viable alternatives to invasive mechanical fasteners. Biocompatible and biodegradable polymers are attractive candidates for versatile bioadhesives and could revolutionize surgical procedures. Bioadhesives can be broadly placed into two groups: activated and instant. Almost all commercially available bioadhesives are instant, which cross-link by mixing two components or on contact with moisture. Activated bioadhesives, on the other hand, allow control of when and where a bioadhesive cross-links and, in some cases, the extent of cross-linking. Despite significant progress, there has been little translation of activated bioadhesives to clinical use. This review discusses recent developments in UV-activated bioadhesives toward addressing unmet clinical needs.
■ INTRODUCTION
Tissue bonding has forever been a problem for humankind, from closing wounds on the battlefield to sealing incisions after surgery. To this end, mechanical fasteners have been used in various forms throughout history: ancient civilizations used bone needles and sutures made from cat-gut, 1−3 South American cultures stapled wounds with the pincer-like jaws of ants, 3,4 and the Romans closed blood vessels with gut ligatures after amputations. The European medical renaissance saw the introduction of cauterizing open wounds with heat and the rediscovery of ligating blood vessels. Despite the advent of modern medicine, mechanical fastening remains the primary method of closing wounds and surgical incisions, 1,5 and the most notable innovations are biodegradable sutures and drug eluting dressings. 6, 7 Apart from causing local trauma and patient discomfort, suturing can be prohibitively difficult, such as anastomosis of capillaries during hand surgery, and unfeasible in the case of sealing the pleural membrane after lung biopsy (8−64% patients suffer pneumothorax as the biopsy needle is removed 8 ). On the other hand, for a skilled hand suturing is fast and effective, offers tactile feedback, and is augmented by robotics for more precise application. The global market for surgical sealants and adhesives is dominated by three products: TISSEEL (Baxter; fibrin), BioGlue (CryoLife; bovine serum albumin and glutaraldehyde), and DERMABOND (Ethicon; cyanoacrylate). 9 These products represent a USD $673 million global market as of 2013, which is expected to reach USD $845 million by 2018, a tiny fraction of the USD $8.6 billion market for advanced wound therapies. 9 Bioadhesives have tremendous potential for advanced healthcare, from reducing surgery time and cost to delivering therapeutic agents and facilitating new minimally invasive procedures.
Two major milestones in the development of bioadhesives are hemostatic sealants and cyanoacrylate (CA) topical skin adhesives. Hemostatic sealants consist of fibrin and thrombin, proteins involved in the natural blood clotting process, 10,11 and initiate the blood coagulation cascade. Despite being effective at stopping blood loss, hemostatic sealants suffer inferior mechanical properties, and their human or bovine origin raises sensitive ethical concerns. 10−12 CA rapidly polymerizes on contact with water, forming a physical barrier against blood flow, 11−13 and was used for emergency wound closure during the Vietnam War. The exothermic polymerization prevented widespread use, until 2-octyl cyanoacrylate (which has a lengthened alkyl chain that slows the polymerization) was approved by the Food and Drug Administration (FDA) for topical wound closure in 1998. 11 Nonetheless, toxic and inflammatory side effects remain a concern and limit CA to topical wound closure and emergency use. 13 More recently, biocompatible polymers such as poly(urethane) (PU) 14 and poly(ethylene glycol) (PEG) 15−19 have been used as backbones in two-part bioadhesive formulations that cross-link upon mixing for use in vivo. Similar two-part bioadhesives employ bovine serum albumin and aldehyde groups as a vascular sealant; however, glutaraldehyde can cause adverse local inflammatory reactions. 20 Examples such as these highlight the progress in bioadhesive development. Nonetheless, twopart instant adhesives have limited application time after mixing, adhere to any surface that they wet, and have predetermined mechanical properties. Despite these limitations, the majority of commercially available bioadhesives are of the instant variety, as illustrated in Figure 1 .
Activated bioadhesives, on the other hand, allow the user to control the onset of cross-linking, thus giving better control of the application site, and can allow tuning of the mechanical and adhesive properties to match the surrounding tissue. 21 This has the advantage of avoiding interfacial stress concentration, which is often the cause of bond failure. Research on activated bioadhesives is dominated by UV-sensitive cross-linking chemistries; bioadhesives activated by IR light, 22−27 RF radiation, 28, 29 heat, 30, 31 and atmospheric plasma 32, 33 have been reported, but these represent a small subset of the field and will not be discussed further. There have been several informative reviews of instant bioadhesives 34 and commercially available bioadhesives/sealants 11, 35 in recent years. The purpose of this review is to highlight recent developments in UVactivated bioadhesives that may have a disruptive impact on healthcare by allowing end-user control over the onset of adhesion and mechanical properties of the adhesive.
■ UV-ACTIVATED BIOADHESIVES
The popularity of UV-cross-linking chemistries reflects the ease with which free-radical polymerization can be triggered with biocompatible photoinitiators. 43−45 In most cases, natural or synthetic polymers chosen from the FDA Compendium of Biomaterials 46 are chemically modified with acrylic groups (acrylated) and mixed with a photoinitiator. Many of these polymers can form stable hydrogels through hydrogen or ionic bonding, but long gel times and poor mechanical properties limit their usefulness as bioadhesives. Acrylation allows rapid cross-linking by free-radical polymerization of acrylic groups. While this approach can be applied to a wide range of polymers, toxic effects may arise from unreacted pendent acrylic groups and photoinitiators leaching into surrounding tissue during degradation. Alternatives to acrylation have begun to emerge, which we will discuss in the following section.
Acrylic Formulations. Natural polymers, such as dextran [43] [44] [45] 47, 48 and sodium alginate, 49−52 have been widely used in bioadhesives. Dextran has been conjugated with 2isocyantoethyl methacrylate (IEMA) to give dextran-urethanemethacrylate (Dex-U) [43] [44] [45] 47 and also with acryloyl chloride to give dextran-acrylate (Dex-A). 48 Similarly, sodium alginate has been conjugated either with 2-aminoethyl methacrylate (AEMA), 50 styryl-pyridine, 51 or methacrylic anhydride. 52 Using Irgacure 2959 as a photoinitiator, these formulations cross-link within 10 min upon exposure to 320−400 nm light (UVA) with doses from 3 to 30 J cm −2 . A range of copolymers has been reported, including acrylate epoxidized soybean oil (AESO), 48 gelatin, 52 and PEG-DOPA. 47 DOPA residue is found on the adhesive protein secreted by marine mussels for underwater adhesion and has been used as an instant mucoadhesive. 53 Similarly, synthetic polymers such as poly(glycerol sebacate) (PGS), 54 poly(vinyl acetate) (PVA), 55, 56 PEG, 57, 58 and poly(εcaprolactone) (PCL) 59−61 have been acrylated for subsequent UV activation using either Irgacure 2959 or Darocur 2959 as a photoinitiator. A prepolymer of PGS acrylated with acryloyl chloride (poly(glycerol sebacate acrylate); PGSA) was crosslinked using 320−390 nm light (UVA) with a dose of 1.9 J cm −2 in 5 s. 54 The mechanical properties of PGSA are comparable to those of human soft tissue, 62−64 and the adhesive was found to entangle with native collagen fibers. 54 UV-PVA (PVA modified with acryloyl chloride) has been reported as a copolymer with acrylated DOPA, although the activation time was 15 min. 55, 56 PEG diacrylate (PEG-DA) has been reported as a skin adhesive that cross-links upon exposure to 350−500 nm light (UVA) with a dose of 86.8 J cm −2 in 7 s. 57 PEG has also been modified with acryloyl chloride and crosslinked with 320−480 nm light (UVA); however, a dose of 9 J cm −2 resulted in a cure time of 15 min. 58 PCL, modified with IEMA cross-linked in 1 min; however, the authors did not specify the wavelength or intensity of light used. 59 L-Lactic acid has been modified with isocyanate-functional unsaturated acrylic ester (LAROMER LR 9000) and cross-linked by 40 CryoLife BioGlue Surgical Adhesive, 41 and FocalSeal-Synthetic Absorbable Sealant. 42 irradiation at 254−354 nm (UVA−UVC) for 120 s 60 and also modified with methacrylic anhydride and cross-linked in the same manner, 61 but the UV intensity was not mentioned.
Photoactive Azide Pendant Groups. An interesting alternative to acrylic formulations are photoactive azides. Chitosan, a hemostatic poly(aminosaccharide), has been modified via free amine groups with lacto bionic acid (allowing solubility in aqueous, nonacidic medium) and with p-azido benzoic acid to allow cross-linking by 300−380 nm light (UVA−UVB) in 1 min via nitrene formation, although the intensity was not specified. 65, 66 The activated chitosan formed a hydrogel that proved more effective than sutures and fibrin glue (TachoComb) in a rat liver injury model 65 and was comparable to fibrin glue for ex vivo nerve anastomosis. 66 The addition of PEG has been shown to improve the adhesive strength of the hydrogel by reaction of one −OH end of PEG with reactive species from photoactivated azide, which resulted in entanglement of pendant PEG chains and the formation of a semiinterpenetrating network. 67 A benefit over acrylic formulations is that they required no photoinitiators for activation. Nitrogen was a side product, which created a gas-filled, sponge-like matrix. This may be seen as an advantage, since it expands upon activation (acrylate and epoxy-based adhesives shrink upon propagation), or a disadvantage, in that mechanical properties will be limited to moduli in the kPa range. Another downside that limits exploration of azido groups is their explosive nature and nucleophilic character that is speculated to give them a limited shelf life.
Metal-Ion Complexes as Photo-oxidizers. In contrast to using photoinitiators to generate free radicals, ruthenium photochemistry has been used to cross-link gelatin using a halogen lamp (300−1200 nm; UVB−vis), although the dose was not specified. 68 Gelatin was mixed with sodium persulfate and the ruthenium metal-ion complex [RuII(bpy 3 )] 2+ , as illustrated in Figure 2 . Tensile adhesive strength to bovine amnion was 5-times higher than fibrin controls, and a sheep lung injury model was successfully sealed. 68 The adhesion mechanism is fast, requiring only seconds of irradiation, but is ultimately limited to protein environments that are rich in tyrosine; this makes it ideal as a tissue sealant but does not allow expansion into adhesion of synthetic biomaterials.
Photoacid Generators for Deprotecting DOPA Functional Groups. Interestingly, researchers have developed a method of caging a functional group similar to the catechol group of DOPA, which is deprotected upon exposure to visible light (UV-filtered mercury xenon lamp), resulting in poly-DOPA mediated cross-linking. 69 This process is illustrated in Figure 3 . A unique advantage of this mechanism is that it allows reversible bonding. The inclusion of a photoacid generator allows reversible adhesion owing to locally reduced pH on exposure to visible light, disrupting the catechol−Fe3 + complex. 70, 71 While the sensitivity to visible light inherently limits the application as a bioadhesive, the use of deprotecting groups is an innovative approach to photoactivation. However, the deprotection kinetics will need to be optimized for clinical application, as the reported formulation required 30 min of irradiation to complete deprotection.
Photoactive Diazirine. Diazirine is an emerging candidate for UV-activated adhesives, as it decays to carbene (a known polymerization catalyst 72 ) upon irradiation with 365 nm (UVA) light. We have functionalized poly(lactide-co-glycolide) (PLGA) thin films with diazirine that cross-link to tissue upon irradiation with 365 nm light at a dose of 300 mJ cm −2 in 10 min. 73 We have also functionalized poly(amido amine) (PAMAM) dendrimers with diazirine, as shown in Figure 4 , for activation either by low-voltage electrical stimulation 74 or UV light. 21 Unlike free radical-mediated acrylate polymerization, carbene-mediated cross-linking allows control over both initiation and propagation; thus, adhesion, viscoelasticity, and modulus can be tuned via the UV dose. Diazirine (among other carbene precursors) is similar to the azido-functional groups in that it requires no free radical initiators for activation and the only leachant is benign diatomic nitrogen, N 2 . The gas byproduct produces a foamed matrix, expanding under activation, which is the opposite of most adhesives that contract and shrink. One important advantage diazirine has 
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Review DOI: 10.1021/acs.biomac.6b01743 Biomacromolecules XXXX, XXX, XXX−XXX C over azido groups is its higher activation wavelength; additionally, it does not have the explosive sensitivity for which azido groups are known. However, like the chitosanazido bioadhesive discussed above, effective moduli will be limited to the kPa range due to N 2 generation.
■ DISCUSSION
Adhesion to Wet Tissue. Physical adhesion is the quintessential adhesion mechanism, where a liquid adhesive flows between adherent surfaces and locks in place upon hardening. The result is exquisite contact between adhesive and substrate and, subsequently, strong adhesion from weak interactions such as hydrogen bonding, exemplified in biomimetic dry adhesives. 75 Such intimate contact is shown in histology micrographs 21, 27, 68 in Figure 5 . Physical adhesion can be enhanced via entanglement of polymer chains and collagen fibers, 54 which can occur in such close proximity. Chemical adhesion is distinguished by covalent bonding between adhesive and substrate, resulting in a stronger bond than physical adhesion alone. In the context of bioadhesion, chemical bonding is facilitated by proteins on the surface of soft tissue.
In the case of acrylic groups, chemical bonds can be formed with nearby thiols on cysteine residues and amino groups on lysine residues 76,77 of membrane proteins. Individual lysine residues, however, are usually protonated at physiological pH and therefore inactive toward acrylic groups. Free radical polymerization in general offers a route for chemical bonding by radical propagation to the tissue surface, which can initiate chain transfer to (and subsequent polymer chain growth from) the tissue surface. Polymerization from the tissue surface can also be facilitated by surface activation using, for example, atmospheric plasma to generate surface free radicals. 33, 73 In contrast, carbene and nitrene radicals can insert into most carbon−hydrogen bonds, potentially allowing a higher density of chemical bonds to tissue than acrylic adhesives. Both physical and chemical bonding are complicated by the presence of water on the tissue surface, which can prevent direct contact between the adhesive and tissue. This is especially problematic for acrylic formulations that react with water, as cross-linking may occur to the water molecules instead of tissue. Design of adhesive formulations to displace the water layer, for example, by swelling/expansion of hydrogel adhesives or physical exclusion by hydrophobic formulations, would make chemical bonding more likely.
Mechanical Properties and Adhesive/Cohesive Failure. Tuning the mechanical properties of a bioadhesive to those of surrounding tissue is crucial to avoid interfacial stress concentrations, which are the leading cause of bond failure. Most UV activated bioadhesive formulations allow control over the final material properties by the relative concentrations of constituent parts, but this is typically set by the manufacturer, with the end-user having little to no control. Tuning mechanical properties during application, for example, by controlling UV intensity or activation time, 21 makes for a versatile bioadhesive that can be applied to a range of tissue surfaces and synthetic biomaterials.
Viscoelastic adhesives can mitigate stress concentration via stress relaxation across the interface. Interpenetrating networks are attracting much attention for biomedical applications as they employ both chemically cross-linked and hydrogenbonded polymer networks to give a tough, viscoelastic material. 67, 78, 79 The drawback of using IPNs for bioadhesives is that they may be limited to certain adhesive chemistries (acrylates have shown the best results to date) and the hydrogen bonded network increases the viscosity of the adhesive prior to activation, causing a trade-off between initial tissue wetting and final adhesive toughness.
Challenges for in Situ Photoactivation. The delivery of UV light to the treatment site of a bioadhesive poses a significant engineering challenge and potential barrier to clinical use. For example, closure of surgical incisions requires penetration of UV light throughout the depth of the incision, and closure of arterial defects requires laparoscopic delivery of UV light via a fiber optic catheter. There are numerous commercially available fiber optic light guides with a range of light output configurations for visible and infrared light (for use 
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Review DOI: 10.1021/acs.biomac.6b01743 Biomacromolecules XXXX, XXX, XXX−XXX D in photodynamic therapy, for example); however, there has been little progress in the delivery of UV light. Despite this, there are several promising developments for in situ light delivery. Biodegradable polymers have been used as planar waveguides to scatter IR light throughout an incision, becoming part of the bioadhesive themselves, as shown in Figure 6 . 80 Also, in situ UV generation has been reported for controlled drug release from polymer matrices 81 using metamaterials (lanthanide-doped LiYF 4 nanoparticles) to up-convert incident IR light to locally emitted UV light. 82 Beyond the challenges of light delivery, UV irradiation may damage nearby healthy tissue. The harmful effects of UV light are wavelength-and dose-dependent; safe exposure limits for UV radiation are shown in Figure 7 for UVA (315−400 nm), UVB (238−315 nm), and UVC (100−280 nm) wavelengths. 83 These safe exposure limits were determined for highly sensitive skin (i.e., melano-compromised) and provide a context in which to evaluate the safety of UV bioadhesives. The majority of the articles reviewed here employed UVA wavelengths at doses from several J cm −2 to several tens of J cm −2 , putting them at the limit of safe exposure for sensitive skin. Moreover, some reports do not state the wavelength 59, 62, 70, 84 or the intensity, 59, 65, [67] [68] [69] [70] [71] 84 making evaluation of UV safety difficult, whereas others use harmful UVB and UVC wavelengths. 60, 65, 66 Future Perspectives. The major breakthroughs in tissue fixation in the past century have been resorbable sutures, fibrin sealants, and cyanoacrylate glue. Sutures are invasive, fibrin glue is a poor adhesive, and cyanoacrylate is cytotoxic and restricted to topical and emergency uses only. Although research efforts have focused on developing novel bioadhesives, there has been little translation to clinical use. The few commercially available bioadhesives are of the instant cross-linking variety, which are limited in their usefulness, offering little control over final mechanical properties and adhering to every surface they touch. Activated bioadhesives offer several advantages over instant, e.g., control over when, where, and for how long an adhesive is cross-linked.
Almost exclusively, UV irradiation has been the preferred activation method, owing, we assume, to the convenience of cross-linking acrylic groups via UV photoinitiators. This has led to a wealth of literature on acrylic-based bioadhesives, where the novelty is in the choice, and acrylation of, the polymer backbone. While Irgacure 2959 and Darocur 2959 are biocompatible, unreacted acrylic monomers (or pendant groups cleaved during degradation) could penetrate nearby tissue and cause local toxicity, which is a major drawback for any implantable material. Breaking the reliance on the acrylation/ photoinitiator combination will be a significant step forward for UV bioadhesives, and this has already begun. UV-activated deprotecting groups, 69−71 photoactive azides, 65, 66 and carbene radical cross-linking 21, 74 offer innovative alternatives to acrylation and provide exciting prospects for next-generation bioadhesives.
Unmet Clinical Applications. Equally exciting are the potential applications of these bioadhesives. With closer interaction between researchers and clinicians comes awareness of unmet clinical needs, to which bioadhesives development can be tailored. Instead of replacing sutures for wound closure, UV bioadhesives have the potential to enable new procedures for which no tissue fixation method currently exists. The potential applications of UV bioadhesives go beyond the suggestions below, but they serve as high-impact areas where the ondemand adhesive activation may be most relevant in terms of current and reported fixation methods.
Sports Lacerations. In contact sports such as hockey and boxing, the most common injury is skin lacerations that occur on unprotected areas, such as facial and ocular protrusions. An ideal tissue adhesive for skin lacerations requires a waterresistant covering, anisotropic elastic modulus, infection preventative, minimal followup, and cosmetic acceptance. DERMABOND, activated by moisture, has been employed toward sports lacerations with some success; however, the octyl-cyanoacrylate formulation requires a minimum of 150 s for maximum bonding strength. 85 Unrestrained polymer propagation does not allow tuning the cured matrix mechanical , 315 nm (500 mJ cm −2 ), and 400 nm (10 5 mJ cm −2 ) for melanocompromised skin. 83 Biomacromolecules Review DOI: 10.1021/acs.biomac.6b01743 Biomacromolecules XXXX, XXX, XXX−XXX properties, giving moduli 1000 times greater than the soft tissues to which it is bonding. Paired with hand-held UV emitting LEDs, UV-activated adhesives may overcome these drawbacks, where curing can be done in less than 60 s (time between boxing rounds) and in a more controlled manner, allowing matching tissue moduli and less interfacial stress.
Laparoscopic and Keyhole Surgeries. Minimally invasive surgeries employ robotics and other thin instruments through small incisions, often far from the tissue of interest. The laparoscope incorporates a fiber optic cable system for illumination and digital viewing devices. As illumination components are already present, it serves as a gateway to activate UV-activatable bioadhesives toward sealants and tissue fixation, which would offer more flexibility than the two-part adhesives and sealants. For example, lung biopsies are a routine out-patient procedure, but they commonly result in lung collapse (pneumothorax) owing to inadequate sealing of the plural membrane. 8 Gelatin sponges and fibrin sealants have had little treatment success, necessitating more advanced designs that allow expansion and wet tissue adhesion. 86, 87 Another example is laparoscopic prenatal surgery, 88−92 where common complications include leakage of amniotic fluid or the separation of placental and embryonic membranes, which can result in premature birth or miscarriage. 93 This leaves open surgery in a procedure similar to a Caesarean section as the preferred option. 94 Injectable bioadhesive sealants may facilitate translation to low-risk, minimally invasive prenatal surgery. 95, 96 A rabbit midgestational model has served to compare two-part tissue adhesives of mussel mimetic adhesive with fibrin sealants. 97, 98 Anastomoses. Arterial and intestinal anastomosis is a procedure used in various surgeries, such as vascular bypass, organ transplant, and excision of colorectal cancers. End-to-end and side-to-end surgical anastomoses are usually created using sutures, which is technically complicated and time-consuming. 99 This approach inflicts additional tissue damage, requires long application times, and could elicit immunological response. A possible alternative route is the application of UV-activatable bioadhesives that either reinforce (through water tight seals) or replace suturing in clinical procedures. Many different bioadhesive formulations have been reviewed, yet few have become part of clinical procedures. 100, 101 Toward colorectal anastomosis, fibrin sealants tend to have more positive results than DERMABOND, which is likely due to the fibrin sealants having a modulus closer to intestinal tissue (kPa) than DERMABOND (MPa). A rat colitis model has recently been described for testing various tissue adhesives toward anastomotic sealing, and this will serve to accelerate clinical development within this area. 102 
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